The European Food Safety Authority (EFSA) has refuted a beta-glucan-based health claim from Nestlé – the Swiss food giant’s first EU health claim submission since 2010. Nestlé’s dossier linked oat and barley beta-glucan-fortified breakfast cereals with blood glucose management – but it was left to cry over spilt cereal milk after EFSA’s 16-strong health claims panel (plus four advisors) baulked over dosage and format.
A Nestlé spokesperson tells NutritionInsight “we’re disappointed” but highlighted “the positive feedback whereby EFSA confirmed the validity of the findings of one of our clinical studies”.
More here.
